Gestalt Diagnostics Announces Advisory Board Formation with Leading Industry Experts
Gestalt Diagnostics has created an Advisory Board led by their Medical Director, Dr. David Hoak. The board consists of Pathologists who have extensive backgrounds in leading edge technology, regulatory expertise and a focus on emerging technologies such as digital pathology.
Advisory board members include:
Dr. Bruce Beckwith, pathologist and Chairman of Pathology at North Shore Medical Center in Salem, MA with an
appointment in Pathology at Massachusetts General Hospital in Boston, MA. Dr. Beckwith serves as the College of
American Pathologists (CAP) liaison to the DICOM Pathology Working Group (WG-26) and was a founding co-chair of
that group. He has also been a member of multiple informatics related committees of the CAP and is currently a member
of the CAP Digital Pathology committee. In addition to his interests in standards development and pathology imaging,
Dr. Beckwith has collaborated on informatics research projects related to making de-identified pathology data and
archival material available for research using a peer to peer networking architecture. When asked about joining the
Gestalt Diagnostics Advisory Board Dr. Beckwith said “I am very excited to work with the team at Gestalt to help inform
the development of software tools that will make it easier for pathologists to adopt digital pathology.”
Dr. Eric Glassy, a community pathologist in Southern California and director of pathology at Providence Little Company
of Mary Medical Center, San Pedro. He is a member of Affiliated Pathologists Medical Group, a 40 person independent
pathology group covering 15 hospitals and laboratories in California, Portland and Phoenix. Dr. Glassy has won a number
of pathology awards, including the Distinguished Service Award and Excellence in Education Award from the College of
American Pathologists (CAP). He has chaired hospital and CAP national committees. He served as chairman of the
Hematology and Clinical Microscopy Resource, Publications, Digital Pathology and Curriculum Committees. He is a past
Board Member of the CAP Foundation and a graduate of the Engaged Leadership Academy. He is past president of the
Digital Pathology Association. He edited, wrote and illustrated several pathology color atlases and developed software
programs for pathology reporting, outreach, and practice management. He holds a green belt in Six Sigma. He is a trustee
of the American Board of Pathology as well as a board member of the CAP. “I am happy to participate in helping Gestalt
roll out their meaningful and impactful digital pathology solution”, says Dr. Glassy.
Dr. John Spinosa, M.D., Ph.D. is the Chief Medical Officer at the San Diego Blood Bank. Dr. Spinosa has a broad
background in clinical and anatomic pathology, hematology, molecular diagnostics and informatics. He spent 20 years at
Scripps Memorial Hospital as Medical Director, Chief of Staff and Chair of Pathology, and has extensive experience in
hospital-based general surgical pathology. He is also entrepreneurial, serving as CMO/Medical Director of local clinical
laboratories at Lexent Bio, Avera, Trovagene, Verinata Health, Prometheus, Esoterix Oncology and other specialty labs.
Dr. Spinosa says, "I look forward to engaging with Gestalt Diagnostics to help provide useful, functional products for the
practicing pathologist that can facilitate the incorporation of whole slide imaging into routine clinical practice. Providing
improved tools is essential in keeping pathology practice vibrant for health systems, physician clients, and patients."
Dr. David Hoak, Gestalt Medical Director, says, "I am pleased and excited that Drs. Eric Glassy, John Spinosa and Bruce
Beckwith are joining the scientific advisory board of Gestalt Diagnostics. Their expertise in informatics and digital
pathology will help refine and improve Gestalt's digital pathology products that seek to improve pathologists' workflow
and efficiency. "
Gestalt Diagnostics is a private, profit-driven software company who has developed PathFlow, an enterprise software
platform specifically designed to bring the benefits of digital workflow to pathologists and pathology
laboratories. This product was originally developed, by what is now Gestalt’s team, to support a fully digital
reading platform for radiology. The radiology platform is used in leading hospitals across the United States and
supports more than 15 million studies annually. Gestalt has expanded and redesigned this proven, robust
solution to work in the laboratory space – engineered for the unique needs and workflow of pathologists.
Roslyn Heights, NY, Sept. 11, 2025 -- Voicebrook, Inc., the leading provider of pathology reporting solutions, today announced a new integration with Gestalt Diagnostics, a leader in digital pathology solutions. This partnership represents the industry's first fully speech-enabled digital pathology solution, enabling laboratories to streamline workflows, reduce inefficiencies, and deliver faster, more accurate results for patients. The integration connects Voicebrook’s VoiceOver PRO reporting platform with Gestalt’s PathFlow digital pathology solution, giving pathologists the ability to control both image navigation and report creation entirely by voice. Pathologists can dictate report sections, complete CAP protocols when required, and seamlessly move between reviewing slides and capturing structured data—all without interrupting their diagnostic flow. " Pathologists face increasing demands to work faster without compromising accuracy, " said Melanie Shedd, VP of Product at Voicebrook. " This integration brings together the best of both worlds—Voicebrook’s proven reporting capabilities and Gestalt’s innovative digital pathology platform—so laboratories can deliver high-quality, CAP-compliant reports more efficiently. " With the combined solution, pathology teams benefit from: Seamless Workflo w: Direct integration between digital slide management and reporting. Efficiency Gains : Voice-enabled navigation and data capture reduce manual entry and workflow disruptions. Flexibility : Support for both narrative reporting and CAP protocols, tailored to any lab’s needs. Improved Collaboration : Enhanced ability for pathologists to share insights and finalize cases quickly. " Gestalt’s mission is to empower pathologists through digital innovation, " said Gestalt’s President, Lisa-Jean Clifford. " Our integration with Voicebrook aligns perfectly with that vision—giving labs a solution that is both powerful and easy to use. " The Voicebrook–Gestalt integration is available now, for laboratories seeking to enhance their digital pathology and reporting capabilities. ### About Voicebrook: Founded in 2002, Voicebrook is the leading provider of reporting solutions for pathology, with approximately 3600 users at 500 sites worldwide. The company’s VoiceOver PRO and SynoptIQ software applications allow pathology professionals to rapidly and accurately create pathology reports. VoiceOver PRO incorporates speech recognition, digital dictation, customizable templates, CAP eCP, and an assortment of input devices, providing direct integration with the user’s Anatomic Pathology (AP) system. SynoptIQ is a full-featured eCP solution solely focused on CAP cancer reporting. Learn more at www.voicebrook.com About Gestalt Diagnostics: Gestalt Diagnostics transforms pathology through an intelligent, configurable, vendor-neutral, and AI-driven digital workflow that provides true interoperability enabling pathologists to diagnose diseases faster and more efficiently. The company's PathFlow® solution is a cloud-based digital pathology enterprise platform that can easily be customized based on your specific preferences. The platform consists of professional, education, and research modules for ease of mixing and matching the digital needs of your facility in a single solution, freeing pathologists from tedious, repetitive, and manual tasks allowing them to focus on their expertise, providing invaluable expertise where it matters most. To learn more, visit www.gestaltdiagnostics.com
With the focus on digital pathology adoption around the globe today, efficiency and accuracy are an expected advantage for deployments in pathology labs of all sizes and types. With the continued advancement of these technologies, solutions like PathFlow and its lighter version, PathCloud, are revolutionizing the way pathologists manage their workflows. With PathFlow and PathCloud’s robust cloud-based capabilities, you have secure access your cases and images anywhere and anytime. With it truly interoperable infrastructure, PathFlow provides streamlined access, routing, and tools directly within the pathologists workflow. Pathology is becoming more in demand, case loads are increasing, pathologist availability is decreasing and the prediction for the number of new patients being diagnosed are all adding strain to the laboratory and the physicians. With a purpose designed infrastructure, PathFlow is made to decrease the manual workload and increase workflow optimization. PathCloud, the cloud-based lighter application to PathFlow, helps ensure pathologists can have access to tools and data from virtually anywhere on the globe in a cost effective, low footprint entry point to digital pathology. PathCloud’s secure environmen delivers real-time access to high-quality images and your case information. Both applications provide enhanced security and efficiency for your peace of mind.
By Maarion Napora At Gestalt, we understand the role of education for physicians and why it is important to have a focus specifically on pathology. It is our goal to provide the proper digital tools and platforms for pathologists to learn how to use the latest technology in their training. PathFlow ’ s Education Module provides academic medical centers and residency programs with leading tools and digital technology to train the next generation of pathologists. Designed to meet the demands of modern techniques, the module offers the ability to develop courses, easily clone and copy courses, and assign teaching lists, images, and tests. You can set the timing for a course, automatically send out messages to remind students of outstanding courses and test deadlines, etc. We support multiple forms of media, including videos, PowerPoint presentations, and word documents. These enable educators to deliver immersive, digital-first learning experiences. The PathFlow Education Module Revolutionizes pathology training by providing a unified platform for interactive learning. Trainees can access a comprehensive library of annotated digital slides, practice diagnosing complex cases, and receive real-time feedback. Professors can easily grade, provide comments and feedback on assessments, and can even assign certificates. The module’s credentialing management capabilities streamline competency assessments, notifications for deadlines, and reminders if not completed, ensuring residents meet rigorous standards while tracking progress seamlessly. We believe education and access to leading technology is the cornerstone of advancing pathology. With PathFlow’s Education Module, we’re empowering academic programs to train confident, tech-savvy pathologists, who will lead the field forward with current skills in available technology informatics.
Spokane, Washington, July 9, 2025 – Gestalt, a leading provider of AI-powered digital pathology solutions, showcased its AI-powered pathology platform, PathFlow, at the Spring 2025 DICOM WG-26 Interoperability Connectathon, confirming its readiness for real-world clinical integration and multi-vendor environments. The Connectathon was co-sponsored by the Digital Pathology Association (DPA) and the European Society of Digital and Integrative Pathology (ESDIP). The event, hosted virtually from January to June and featured at the European Congress on Digital Pathology in Barcelona, brought together over 30 organizations to validate end-to-end workflows, in varying categories, using DICOM standards. The categories included image acquisition, storage, viewing, and AI-driven annotations. Gestalt’s platform stood out as a leader in interoperability, particularly as an Image Display (Viewer). Gestalt’s Viewer successfully displayed images from 8 of 9 different WSI Scanners, demonstrating seamless compatibility with multiple diverse systems such as 3DHISTECH, Grundium, Leica, Hamamatsu and Pramana. This robust performance ensures pathologists can access high-quality whole slide images effortlessly, regardless of the source, streamlining diagnostic workflows. Additionally, PathFlow excelled in displaying annotations from five AI Evidence Creators, including industry leaders like Visiopharm, Hologic, TechCyte and identify.bio, further demonstrating its ability to present structured data for precise diagnostic insights. As an Evidence Creator itself, (AI Annotations), Gestalt showcased its advanced AI capabilities, by analyzing and annotating images from eight scanners. These annotations were successfully transmitted to five different image management archives using standard DICOM Web protocols, highlighting Gestalt’s ability to deliver accurate, standards-compliant AI-driven outputs. This functionality empowers pathologists to integrate AI seamlessly into routine clinical operations, improving efficiency and diagnostic accuracy. “Gestalt’s performance at the Connectathon reflects our dedication to building interoperable, scalable solutions that empower pathologists globally,” said Brian Napora, VP of Innovation, Gestalt Diagnostics. “By investing in open standards, we’re helping lead digital pathology toward a more integrated and intelligent future.” The Connectathon’s rigorous testing environment validated Gestalt’s ability to handle real-world challenges, such as legacy image integration and complex multi-vendor workflows without requiring custom workarounds. Gestalt’s commitment to DICOM standards positions PathFlow as a cornerstone for vendor-neutral, future-ready pathology solutions. About Gestalt Gestalt Diagnostics is a Spokane-based company dedicated to revolutionizing pathology through digital solutions. Founded in 2017, Gestalt provides advanced technology, proven digital expertise, and artificial intelligence to enable pathologists to diagnose diseases faster and more efficiently. The company's PathFlow platform is at the forefront of digital pathology innovation, offering significant improvements in diagnostic accuracy and workflow efficiency. To learn more, visit www.gestaltdiagnostics.com and follow @Gestalt on LinkedIn
July 2025 Digipath Dispatch – Industry news, digital pathology insights, product updates, and events from Gestalt Diagnostics.
Gestalt’s PathFlow and PathCloud unify pathology workflows, enabling seamless, multi-vendor integration for faster, accurate diagnoses.
Discover why digital pathology is gaining momentum and how it’s shaping diagnostics, improving workflows, and addressing workforce challenges in healthcare.
Discover how Lisa-Jean Clifford is helping shape the future of AI in pathology through a new framework designed for safe, scalable clinical integration.
Spokane, Washington, June 17, 2025 – Gestalt, a leading provider of AI-powered digital pathology solutions, today announced the addition of Dr. Renuka Kulkarni, MD, as Chief Medical Officer (CMO). A physician scientist with over 20 years of experience in surgical and digital pathology, Dr. Kulkarni will join the team in guiding Gestalt’s product direction and clinical usability. Dr. Kulkarni brings a rare blend of diagnostic precision and scientific innovation to the organization. Her expertise in breast pathology, immunomarkers, machine learning, and image analysis strengthens Gestalt’s mission to revolutionize diagnostic workflows and clinical decision-making through technology. “Renuka’s addition signals our deepening investment in the future of pathology,” said Lisa-Jean Clifford, President of Gestalt Diagnostics. “Her leadership and experience at the intersection of clinical insight, AI, and enterprise lab operations will ensure our solutions continue to serve both pathologists and the patients they care for.” Before joining Gestalt, Dr. Kulkarni played a pivotal role in developing one of the earliest digital pathology programs at a leading full-service reference laboratory. Her extensive hands-on experience with Gestalt’s solutions, as a customer and direct user for four years, along with image analysis platforms, and combined with her understanding of real-world lab operations, positions her to help bridge the clinical and commercial realms—ensuring the scalability and impact of Gestalt’s solutions. As CMO, Dr. Kulkarni will help shape the development of next-generation diagnostic tools, supporting Gestalt’s mission to enhance diagnostic accuracy, efficiency, and interoperability across health systems worldwide. “I’m honored to join Gestalt at such a transformative moment in digital pathology,” said Dr. Kulkarni. “Together, we have the opportunity to shape solutions that truly serve pathologists and ultimately improve outcomes for patients everywhere.” About Gestalt Gestalt Diagnostics is a Spokane-based company dedicated to revolutionizing pathology through digital solutions. Founded in 2017, Gestalt provides advanced technology, proven digital expertise, and artificial intelligence to enable pathologists to diagnose diseases faster and more efficiently. The company's PathFlow platform is at the forefront of digital pathology innovation, offering significant improvements in diagnostic accuracy and workflow efficiency. To learn more, visit www.gestaltdiagnostics.com and follow @Gestalt on LinkedIn
Date : Wednesday, May 21, 2025 Time : 1:45 PM Location : Auditorium 1, Marriott Eagle Crest Resort (Ann Arbor, Michigan) Session Title : The Long-Term Advantages of Digital Pathology are Only Realized Through True Interoperability We’re proud to announce that Lisa-Jean Clifford , COO & Chief Strategy Officer at Gestalt Diagnostics, and Sumie Edwards (ARUP) will take the stage at the 2025 Pathology Informatics Summit to share key insights into the critical role of interoperability in digital pathology. In this featured session, Lisa-Jean will explore: Why interoperability is the linchpin for scalable, future-ready digital pathology programs How health systems can unlock long-term value and efficiency through seamless integration Real-world considerations for IT infrastructure, workflow design, and cross-platform compatibility Her session will offer a strategic lens into how institutions can achieve meaningful digital transformation, not just implement new tools. About the PI Summit : The Pathology Informatics Summit is a premier annual event for professionals at the forefront of digital pathology, laboratory medicine, AI, and healthcare data innovation. It brings together leading physicians, researchers, and informaticists to discuss the rapidly evolving field. Mark your calendar for May 21 at 1:45 PM to hear Lisa-Jean share her vision for a more connected and impactful future in pathology.
